SCHEMBL1999507

SCHEMBL1999507

[2H]C([2H])(OCc1ccccc1)c1ccc(OCc2ccccc2)c([C@H](CC(=O)Cl)c2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.39
ACP1 P24666 1/20 0.39
PTPN12 Q05209 1/20 0.39
PTPN13 Q12923 1/20 0.39
SSU72 Q9NP77 1/20 0.39
PTGER1 P34995 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
GLRA1 P23415 1/20 0.38
FFAR1 O14842 1/20 0.38
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SLC6A9 P48067 1/20 0.37
SLC6A5 Q9Y345 1/20 0.37
CTSA P10619 2/20 0.36
HPGD P15428 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989783 0.92 KMT2A (0.44) FOLH1ACP1PTPN12PTPN13SSU72
SCHEMBL1992692 0.91 FOLH1 (0.42) FOLH1ACP1PTPN12PTPN13SSU72
SCHEMBL1992690 0.91 FOLH1 (0.42) FOLH1ACP1PTPN12PTPN13SSU72
SCHEMBL4306326 0.89 PTGER1 (0.36) FOLH1ACP1PTPN12PTPN13SSU72
SCHEMBL1995601 0.84 CHRM2 (0.39) FOLH1ACP1PTPN12PTPN13SSU72
SCHEMBL1990399 0.83 KMT2A (0.47) FOLH1ACP1PTPN12PTPN13SSU72
SCHEMBL1990402 0.83 KMT2A (0.47) FOLH1ACP1PTPN12PTPN13SSU72
SCHEMBL1990015 0.82 ACP1 (0.37) FOLH1ACP1PTPN12PTPN13SSU72
SCHEMBL1989523 0.81 PTGER1 (0.46) ACP1PTPN12PTPN13SSU72PTGER1
SCHEMBL2167258 0.81 LRRK2 (0.46) PTGER1HPGDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF CONCERT PHARMACEUTICALS INC. (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF ADRB3, CHRM3, QDPR FOLH1 407/4885ACP1 4342/4885PTPN12 3011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.